The most validated biological marker in non-metastatic breast cancer are tumor size, histological grade, mitotic index, Ki67 rate, axillary lymph node involvement, Estrogen Receptor (ER), Progesterone Receptor (PR) and HER2 status. This evidence concerns the gene ERBB2 and breast cancer.